EUVIMEDAvasta EUVIMED
Crossref

Recipient Outcomes After Utilization of Kidneys From Deceased Donors With Diagnosed Glioblastoma Multiforme

Venkata Kanaka Naga Karthik Nasika iD, Vanjinathan Subramani iD, Ashish Sharma iD, Sarbpreet Singh, Jasmine Sethi, SreeVani Paladugu iD, Kajal Jain, Navdeep Bansal iD

Clinical Transplantation · 2025

DOI: 10.1111/ctr.70090 ↗

At a glance

Journal article in Clinical Transplantation, 2025. Written by Venkata Kanaka Naga Karthik Nasika and 7 co-authors. Institution: Department of Renal Transplant Surgery, Postgraduate Institute of Medical Education and Research, Chandigarh, India. Major MEDLINE topics: Kidney Transplantation, Glioblastoma, Tissue Donors, Brain Neoplasms. 36 references.

AbstraktSubjectsBibliograafilised andmedCiteRelated studies

Abstract (original language)

Background

The exact incidence of donor tumor transmission in patients with glioblastoma multiforme (GBM) is still unknown. These transplants are usually considered as a high‐risk endeavor due to fear of potential spread especially with medical intervention leading to breach in blood–brain barrier. This report describes successful outcomes after renal transplantation from two donors with World Health Organization (WHO) Grade IV primary GBM who had undergone surgical excision with ventriculoperitoneal shunt (VPS).

Methods

Between January 2019 and June 2024, case records of organ donors where the primary cause of death was GBM were screened from the departmental database. Renal transplant patients from donors with a histopathological diagnosis GBM WHO Grade IV were included in the study. The follow‐up of these recipients was recorded for tumor transmission, delayed graft function, patient and graft survival.

Results

Only kidneys were retrieved from these donors. The donor's kidneys were transplanted to four consented recipients after taking informed consent explaining the risks. During the mean follow‐up of 3 years, all four patients were alive with good graft function. Nuclear scan at 3, 6 months, and yearly thereafter showed no abnormal uptake or no evidence of donor‐transmitted tumor transmission in any of these patients.

Conclusion

High‐grade GBM donors with no evidence of systemic spread may be considered for renal transplantation.

Subjects

MeSH terms (MEDLINE)

Kidney TransplantationGlioblastomaTissue DonorsBrain NeoplasmsHumansMaleFemaleFollow-Up StudiesMiddle AgedPrognosisAdultGraft SurvivalTissue and Organ ProcurementRetrospective StudiesTransplant RecipientsRisk Factors

Authors and institutions

  • Department of Renal Transplant Surgery, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
  • Department of Nephrology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
  • Department of Anaesthesiology and Intensive Care, Postgraduate Institute of Medical Education and Research, Chandigarh, India.

ORCID profiles: Venkata Kanaka Naga Karthik Nasika, Vanjinathan Subramani, Ashish Sharma, SreeVani Paladugu, Navdeep Bansal

Cite

APA

Nasika, V. K. N. K., Subramani, V., Sharma, A., Singh, S., Sethi, J., Paladugu, S., Jain, K., & Bansal, N. (2025). Recipient Outcomes After Utilization of Kidneys From Deceased Donors With Diagnosed Glioblastoma Multiforme. Clinical Transplantation. https://doi.org/10.1111/ctr.70090

Vancouver

Nasika VKNK, Subramani V, Sharma A, Singh S, Sethi J, Paladugu S, et al. Recipient Outcomes After Utilization of Kidneys From Deceased Donors With Diagnosed Glioblastoma Multiforme. Clinical Transplantation. 2025. doi:10.1111/ctr.70090

BibTeX
@article{Nasika2025,
  author = {Nasika, Venkata Kanaka Naga Karthik and Subramani, Vanjinathan and Sharma, Ashish and Singh, Sarbpreet and Sethi, Jasmine and Paladugu, SreeVani and Jain, Kajal and Bansal, Navdeep},
  title = {Recipient Outcomes After Utilization of Kidneys From Deceased Donors With Diagnosed Glioblastoma Multiforme},
  journal = {Clinical Transplantation},
  year = {2025},
  doi = {10.1111/ctr.70090}
}
Start for free →